VJOncology is committed to improving our service to you

ELCC 2019 | The LUNAR study: TTFields for NSCLC

VJOncology is committed to improving our service to you

Ori Farber

Here Ori Farber, MD, of Novocure, Haifa, Israel, gives a background of the ongoing LUNAR study (NCT02973789) using tumor treating fields (TTF) to treat patients with non-small cell lung cancer (NSCLC) following progression while on or after platinum based treatment. This video was recorded at the European Lung Cancer Congress (ELCC) 2019, held in Geneva, Switzerland.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter